Omnicell 

$41.51
20
-$0.79-1.87% Thursday 20:00

Statistik

Harga Tertinggi Hari
42.23
Harga Terendah Hari
41.4
52M Tertinggi
46.05
52M Terendah
25.12
Volum
282,520
Volum Purata
542,515
Kapasiti Pasaran
2.05B
Nisbah P/E
-
Pendapatan Dividen
-
Dividen
-

Akan Datang

Pendapatan

29OctDijangka
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Seterusnya
-0.09
0.15
0.38
0.62
EPS yang dijangka
0.414782
EPS sebenar
N/A

Orang Lain Juga Mengikuti

Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti OMCL. Ini bukan cadangan pelaburan.

Peserta

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.
Medtronic
MDT
Kapasiti Pasaran113.61B
Medtronic menawarkan penyelesaian pengurusan ubat yang bersaing dengan sistem pengedaran automatik Omnicell.
Becton Dickinson
BDX
Kapasiti Pasaran70.07B
Becton, Dickinson and Company menyediakan penyelesaian pengurusan ubat dan keselamatan pesakit, bersaing secara langsung dengan tawaran Omnicell.
Mckesson
MCK
Kapasiti Pasaran72.76B
McKesson Corporation menyediakan pengedaran farmaseutikal dan penyelesaian rantaian bekalan kesihatan, bersaing dalam ruang pengurusan ubat.
Cardinal Health
CAH
Kapasiti Pasaran27.49B
Cardinal Health menawarkan produk dan perkhidmatan yang menyokong farmasi hospital dan sistem penjagaan kesihatan, bersaing dengan penyelesaian Omnicell.
AMERISOURCEBERGEN CORP
ABC
Kapasiti Pasaran34.08B
AmerisourceBergen Corporation adalah syarikat borong ubat yang bersaing dalam ruang pengurusan farmaseutikal dan pengedaran, bertindih dengan pasaran Omnicell.
Stryker
SYK
Kapasiti Pasaran137.35B
Stryker Corporation menawarkan teknologi perubatan, termasuk penyelesaian pengurusan ubat, yang bersaing dengan produk Omnicell.
Johnson & Johnson
JNJ
Kapasiti Pasaran399.26B
Johnson & Johnson, melalui segmen peranti perubatan, bersaing dalam ruang penyelesaian penjagaan kesihatan, termasuk pengurusan ubat.
GE Aerospace
GE
Kapasiti Pasaran189.34B
General Electric, melalui bahagian kesihatannya, menawarkan teknologi perubatan yang boleh bersaing dengan penyelesaian automatik Omnicell.
Koninklijke Philips N.V.
PHG
Kapasiti Pasaran28.48B
Philips menawarkan penyelesaian penjagaan kesihatan dan peranti perubatan yang boleh bersaing dengan sistem pengurusan ubat dan bekalan Omnicell.

Penilaian Penganalisis

37.6$Sasaran Harga Purata
Anggaran tertinggi adalah $44.
Dari 5 penilaian dalam tempoh 6 bulan terakhir. Ini bukan cadangan pelaburan.
Beli
40%
Pegang
60%
Jual
0%

Mengenai

Technology Services
Information Technology Services
Manufacturing
Electronic Computer Manufacturing
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Show more...
CEO
Randall Lipps
Pekerja
3630
Negara
US
ISIN
US68213N1090

Penyenaraian